Introduction {#s1}
============

Retinal artery occlusion (RAO) can cause severe and irreversible vision loss. RAO is divided into branch retinal artery occlusion (BRAO) and central retinal artery occlusion (CRAO) based on the site of arterial occlusion. It is most often caused by an embolism resulting in infarction of the inner retina and may be regarded as the ocular analogue to cerebral stroke.[@i2164-2591-8-4-23-b01],[@i2164-2591-8-4-23-b02] Various treatment strategies for the acute management have been explored, such as ocular massage and thrombolysis; however, no treatment has yet been shown to be effective.[@i2164-2591-8-4-23-b03] In order to develop treatment that can limit the extent and severity of ischemic injury, a deeper understanding of the pathophysiology and biochemical processes is needed. Experimental animal models of RAO have the potential to broaden our knowledge of the disease in general and lead to the development of new treatments in particular. Also, retinal tissue is accessible in animal models allowing for advanced analyses directly at the retinal level where RAO is located.

Numerous experimental animal studies of RAO have previously been performed using a variety of different methodologic approaches with varying similarities to human conditions. However, the use of different models for inducing illness and disparate animal species, among other factors, makes it difficult to compare and extrapolate findings with humans.[@i2164-2591-8-4-23-b04] Indeed, criticism has been raised against several of the previously employed methods.[@i2164-2591-8-4-23-b05],[@i2164-2591-8-4-23-b06] Improvement and standardizations of the scientific method followed by systematic review may increase the translational value to human disease.[@i2164-2591-8-4-23-b04]

Therefore, the aim of the present paper was to present a comprehensive overview of previously applied methodologic approaches that can be used for conducting animal models of RAO in order to assist future researchers in deciding on the most ideal experimental setting.

Methods {#s2}
=======

For this review, a systematic literature search was conducted in PubMed and Embase ([Supplementary Tables S1](#tvst-08-04-11_s01){ref-type="supplementary-material"} and [S2](#tvst-08-04-11_s01){ref-type="supplementary-material"}). Prior to the search, a protocol was written. Studies were included if their experimental method induced occlusion of the retinal artery, regardless if their primary aim was to set up a model for RAO or not. The retrieved studies were examined to exclude overlapping or duplicated data. Experimental models of occlusion of vessels more proximal than the ophthalmic artery were excluded, as these more closely resembled manifestations of other diseases, such as ocular ischemic syndrome.

For each included study, the species used in the study was noted, method of inducing the occlusion, time of occlusion, and reperfusion if applicable, as well as validation of the occlusion. Results were presented using narrative synthesis, including discussion of the advantages and challenges in the various methodologic approaches.

Results {#s3}
=======

In all, 268 studies were identified after duplicates were removed, and a total of 83 studies were included ([Fig. 1](#i2164-2591-8-4-23-f01){ref-type="fig"}). Five of the included studies had used more than one method of inducing RAO and therefore each method was included separately in the synthesis. Hence, a total of 88 reports were included.

![Flow chart of study selection procedure.](i2164-2591-8-4-23-f01){#i2164-2591-8-4-23-f01}

The majority of the included studies most closely resembled CRAO. However, 23 induced one or more BRAO. Of these, 13 used lasers,[@i2164-2591-8-4-23-b07][@i2164-2591-8-4-23-b08][@i2164-2591-8-4-23-b09][@i2164-2591-8-4-23-b10][@i2164-2591-8-4-23-b11][@i2164-2591-8-4-23-b12][@i2164-2591-8-4-23-b13][@i2164-2591-8-4-23-b14][@i2164-2591-8-4-23-b15][@i2164-2591-8-4-23-b16][@i2164-2591-8-4-23-b17]--[@i2164-2591-8-4-23-b18] five used embolization,[@i2164-2591-8-4-23-b19][@i2164-2591-8-4-23-b20][@i2164-2591-8-4-23-b21][@i2164-2591-8-4-23-b22]--[@i2164-2591-8-4-23-b23] one used heat coagulation by the use of a probe,[@i2164-2591-8-4-23-b24] and four used a probe or an occluder.[@i2164-2591-8-4-23-b24][@i2164-2591-8-4-23-b25][@i2164-2591-8-4-23-b26]--[@i2164-2591-8-4-23-b27]

Species {#s3a}
-------

A number of different species have been used ([Table 1](#i2164-2591-8-4-23-t01){ref-type="table"}). Rodents are the most commonly used species in the experimental animal models, the second most frequently used species being monkeys. A smaller number of experimental setups included cats, dogs, rabbits, or pigs. Especially, dogs, cats, and pigs were used in studies using methods requiring larger animals (occluder/probe, endovascular techniques, or embolization).

###### 

Animal Species and Techniques Used to Produce Occlusion

                                Rodents, *n*   Rabbits, *n*   Cat, *n*   Dog, *n*   Pig, *n*   Monkey, *n*   Combination, *n*   Total, *n*   References
  ----------------------------- -------------- -------------- ---------- ---------- ---------- ------------- ------------------ ------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Laser, *n*                    14             4              0          0          0          4             1                  23           [@i2164-2591-8-4-23-b07]--[@i2164-2591-8-4-23-b18],[@i2164-2591-8-4-23-b28][@i2164-2591-8-4-23-b29][@i2164-2591-8-4-23-b30][@i2164-2591-8-4-23-b31][@i2164-2591-8-4-23-b32][@i2164-2591-8-4-23-b33][@i2164-2591-8-4-23-b34][@i2164-2591-8-4-23-b35][@i2164-2591-8-4-23-b36]--[@i2164-2591-8-4-23-b37]
  Vasoconstriction, *n*         2              3              0          0          0          1             0                  6            [@i2164-2591-8-4-23-b16],[@i2164-2591-8-4-23-b38][@i2164-2591-8-4-23-b39][@i2164-2591-8-4-23-b40][@i2164-2591-8-4-23-b41]--[@i2164-2591-8-4-23-b42]
  Raised IOP, *n*               9              1              0          0          0          1             0                  11           [@i2164-2591-8-4-23-b43]--[@i2164-2591-8-4-23-b44][@i2164-2591-8-4-23-b45][@i2164-2591-8-4-23-b46][@i2164-2591-8-4-23-b47][@i2164-2591-8-4-23-b48][@i2164-2591-8-4-23-b49][@i2164-2591-8-4-23-b50][@i2164-2591-8-4-23-b51][@i2164-2591-8-4-23-b52][@i2164-2591-8-4-23-b53]
  Clamp, *n*                    0              0              0          0          0          9             0                  9            [@i2164-2591-8-4-23-b05],[@i2164-2591-8-4-23-b18],[@i2164-2591-8-4-23-b54][@i2164-2591-8-4-23-b55][@i2164-2591-8-4-23-b56][@i2164-2591-8-4-23-b57][@i2164-2591-8-4-23-b58][@i2164-2591-8-4-23-b59]--[@i2164-2591-8-4-23-b60]
  Ligation, *n*                 20             1              0          0          0          3             0                  24           [@i2164-2591-8-4-23-b38],[@i2164-2591-8-4-23-b61][@i2164-2591-8-4-23-b62][@i2164-2591-8-4-23-b63][@i2164-2591-8-4-23-b64][@i2164-2591-8-4-23-b65][@i2164-2591-8-4-23-b66][@i2164-2591-8-4-23-b67][@i2164-2591-8-4-23-b68][@i2164-2591-8-4-23-b69][@i2164-2591-8-4-23-b70][@i2164-2591-8-4-23-b71][@i2164-2591-8-4-23-b72][@i2164-2591-8-4-23-b73][@i2164-2591-8-4-23-b74][@i2164-2591-8-4-23-b75][@i2164-2591-8-4-23-b76][@i2164-2591-8-4-23-b77][@i2164-2591-8-4-23-b78][@i2164-2591-8-4-23-b79][@i2164-2591-8-4-23-b80][@i2164-2591-8-4-23-b81][@i2164-2591-8-4-23-b82]--[@i2164-2591-8-4-23-b83]
  Occluder, probe, *n*          0              0              5          0          0          0             1                  6            [@i2164-2591-8-4-23-b24][@i2164-2591-8-4-23-b25][@i2164-2591-8-4-23-b26]--[@i2164-2591-8-4-23-b27],[@i2164-2591-8-4-23-b84]
  Embolization, *n*             0              1              0          2          3          0             0                  6            [@i2164-2591-8-4-23-b19][@i2164-2591-8-4-23-b20][@i2164-2591-8-4-23-b21][@i2164-2591-8-4-23-b22]--[@i2164-2591-8-4-23-b23],[@i2164-2591-8-4-23-b85]
  Endovascular technique, *n*   0              0              0          0          3          0             0                  3            [@i2164-2591-8-4-23-b86][@i2164-2591-8-4-23-b87]--[@i2164-2591-8-4-23-b88]
  Total, *n*                    45             10             5          2          6          18            2                  88           

The resemblance to human anatomy varies widely among the species. In monkeys, the vascular architecture is very similar to humans.[@i2164-2591-8-4-23-b89] Furthermore, monkeys have a macula as in humans, as opposed to the other species included. Overall, the structure of the retinal vascular system of the pig is similar to that of humans too.[@i2164-2591-8-4-23-b90],[@i2164-2591-8-4-23-b91] Diverging results exist regarding the presence of a central retinal artery (CRA) in the pig. Some authors report of a single retinal artery giving rise to several branches,[@i2164-2591-8-4-23-b86] while others report of no formation of a CRA.[@i2164-2591-8-4-23-b92] The findings suggest that the retinal arteries may either arise from the ciliary artery as several branches, or as a single branch, which quickly divides. Once the nerve head is reached, only branches are visualized, typically four.[@i2164-2591-8-4-23-b90]

In contrast to humans and the other species used, both cats and dogs have a tapetum lucidum, which is a reflective layer improving vision in dim light.[@i2164-2591-8-4-23-b93],[@i2164-2591-8-4-23-b94] In the cat, three major arteries and two to six smaller arteries run from the optic disc to the periphery.[@i2164-2591-8-4-23-b95] In the dog, there is no CRA. Instead, multiple vessels pierce the sclera, branching off usually three or four retinal arteries. As opposed to humans, the arteries show tortuosity.[@i2164-2591-8-4-23-b89]

The retinal vascular system of the rabbit eye is distinctly different from the human eye and the other species used in the identified studies as the rabbit retina is merangiotic (presence of blood vessels in a limited part of the retina leaving the rest of the retina avascular).[@i2164-2591-8-4-23-b95],[@i2164-2591-8-4-23-b96] Furthermore, the retinal circulation of the rabbit may play little role in maintaining retinal function as monitored by the electroretinogram (ERG), as suggested by Ciulla et al.[@i2164-2591-8-4-23-b38]

Method of Inducing RAO {#s3b}
----------------------

Overall, RAO was induced by several methods, including laser, vasoconstriction by injection of chemical substances, increased intraocular pressure (IOP), embolization, or arterial occlusion by using a clamp or suture mainly, or by using an occluder ([Table 1](#i2164-2591-8-4-23-t01){ref-type="table"} and [Fig. 2](#i2164-2591-8-4-23-f02){ref-type="fig"}).

![Methods used to induce RAO in the included studies.](i2164-2591-8-4-23-f02){#i2164-2591-8-4-23-f02}

### Laser {#s3b1}

Sixteen studies used laser photocoagulation ([Table 2](#i2164-2591-8-4-23-t02){ref-type="table"}). It was most often performed using an argon laser with wavelengths varying between 514 to 577 nm. Often, a photosensitizing agent was used to increase laser absorption and minimize the amount of laser required to produce occlusion. Hence, nine studies used rose bengal and seven studies used no photosensitizer.

###### 

Parameters of Laser Photocoagulation for Each Study

  Type of Occlusion    Photo sensitizer                 Laser                      Wavelength, nm   Power, mW   Spot Size, μm    Duration, s   Number of Applications, *n*          Reference
  -------------------- -------------------------------- ------------------------- ---------------- ------------ --------------- ------------- ----------------------------- --------------------------
  BRAO                 \-                               NA                               NA             NA      NA                   NA                    NA                [@i2164-2591-8-4-23-b18]
  CRAO (and CRVO)      \-                               Argon                            NA            900      500                0.2--1                  20                [@i2164-2591-8-4-23-b33]
  CRAO (and CRVO)      \-                               Argon                            NA            900      500                0.2--1                  20                [@i2164-2591-8-4-23-b34]
  BRAO                 \-                               Blue--green argon laser          NA          100--200   50                0.1--0.2              Median 44            [@i2164-2591-8-4-23-b10]
  BRAO                 \-                               Argon dye laser                 577             80      50                   0.1                 10--20              [@i2164-2591-8-4-23-b13]
  CRAO                 Rose bengal, 20 mg/kg            Argon green laser               514            100      50                   0.3                   NA                [@i2164-2591-8-4-23-b32]
  BRAO                 \-                               Argon laser                      NA          150--250   100                  0.5                  3--10              [@i2164-2591-8-4-23-b14]
  CRAO                 Rose bengal, 20 mg/kg            Argon green laser               532            100      75                   0.4                   NA                [@i2164-2591-8-4-23-b30]
  CRAO                 Rose bengal, 0.1 mL              Diode laser                     532            490      300                 0.300                  NA                [@i2164-2591-8-4-23-b35]
  RAO (all arteries)   Rose bengal, 50mg/kg             NA                              532            650      75                   0.5                   NA                [@i2164-2591-8-4-23-b37]
  BRAO                 Rose bengal, 100 μL 1%           Diode laser                     532             NA      75                   NA                    NA                [@i2164-2591-8-4-23-b15]
  CRAO                 Rose bengal, 20 mg/kg            NA                              514         100 or 150  200                  NA                    NA                [@i2164-2591-8-4-23-b31]
  CRAO                 Rose bengal, 0.05 mL of 2.5 mM   YAG laser                       514         100 or 150  200                  0.1                   20                [@i2164-2591-8-4-23-b29]
  CRAO                 Rose bengal, 20 mg/kg            NA                              532            150      200                  NA                    NA                [@i2164-2591-8-4-23-b36]
  BRAO                 \-                               Red laser light                  NA            300      NA                   0.3                   NA                [@i2164-2591-8-4-23-b16]
  BRAO                 Rose bengal, 40 mg/kg            Slit-lamp Krypton laser          NA             50      50                   3.0                   2-3               [@i2164-2591-8-4-23-b17]

CRVO, central retinal vein occlusion; NA, not available/not applicable.

Six studies used photodynamic therapy or a photodynamic therapy--like method.[@i2164-2591-8-4-23-b07][@i2164-2591-8-4-23-b08]--[@i2164-2591-8-4-23-b09],[@i2164-2591-8-4-23-b11],[@i2164-2591-8-4-23-b13],[@i2164-2591-8-4-23-b28] In these studies, a photosensitizing agent was administered intravenously or, in one study, intraperitoneally[@i2164-2591-8-4-23-b13] followed by application of laser or another light source for a duration varying from 2 to 45 minutes.

One study used laser to induce targeted delivery of a platelet-activating agent, in this case adenosine diphosphate.[@i2164-2591-8-4-23-b12]

If a CRAO was induced by laser, the laser beam was oriented at the optic disc. If one or more BRAO was aimed for, then the laser beam was targeted at one or more arterioles, typically near the optic disc.

### Vasoconstriction {#s3b2}

Apart from one study using serotonin, vasoconstriction was induced by administration of endothelin-1, which is a potent vasoconstrictor produced by vascular endothelial cells.[@i2164-2591-8-4-23-b39] Generally, endothelin-1 was either injected in the posterior vitreous body over the optic disc, which causes constriction of all retinal vessels, including both veins and arteries,[@i2164-2591-8-4-23-b16],[@i2164-2591-8-4-23-b38],[@i2164-2591-8-4-23-b39],[@i2164-2591-8-4-23-b40] or it was injected in the subconjunctival space in the posterior part of the eyeball causing constriction of the CRA.[@i2164-2591-8-4-23-b41] It is not evident if this last method causes constriction of other vessels too.

Serotonin was used in one study to test the hypothesis that serotonin may cause vasospasm in atherosclerotic monkeys. In total, nine monkey eyes were used, and in four of these an occlusion of the CRA was evident, an additional two showed slight filling delay.[@i2164-2591-8-4-23-b42]

### Raised IOP {#s3b3}

Most frequently, occlusion or ischemia was produced by cannulating the anterior chamber with a tube connected to an elevated reservoir containing saline. The IOP is then elevated to typically 120 mm Hg (range, 90--160 mm Hg). In one study, the IOP was increased by inserting and inflating an arterial embolectomy catheter balloon retrobulbarly to simulate orbital hemorrhage.[@i2164-2591-8-4-23-b43] This resulted in occlusion of the CRA in two of 16 monkeys.

### Clamp {#s3b4}

This method consisted of performing a lateral orbitotomy followed by clamping of the CRA at its site of entry into the optic nerve dural sheath. It was performed on monkeys in all nine studies using this method.

### Ligation {#s3b5}

For this procedure, one study used a clip, the rest used a ligature. For the large majority, the procedure of ligating the CRA in rodents included ligation of the optic nerve and other vessels (posterior ciliary artery). However, two studies using rodents reported applying ligature solely on the CRA,[@i2164-2591-8-4-23-b61],[@i2164-2591-8-4-23-b62] only one of them with a detailed description on how it was done.[@i2164-2591-8-4-23-b62] The optic nerve was exposed by blunt dissection after a lateral conjunctival dissection and removal of the lateral rectus muscle. The CRA was exposed by longitudinally opening the dural sheath surrounding the optic nerve using fine scissors. The suture on the CRA was positioned after the trifurcature of the ophthalmic artery into the CRA and two posterior ciliary arteries.[@i2164-2591-8-4-23-b62]

All three studies on monkeys placed a ligature on the CRA only.

### Occluder/Probe {#s3b6}

In studies using an occluder or a probe, the probe or occluder was either produced from a steel needle or from a glass probe tipped with a glass ball. For heat coagulation, the probe was made by sealing tungsten wire into a glass capillary tube with epoxy.

Two studies used a probe and in an identical fashion. A puncture was made through the superior lateral portion of the pars plana through which the blocker probe was inserted. BRAO was then produced by pressing the probe on a branch artery. By pressing the probe on the optic nerve, it occluded the entire retinal circulation.[@i2164-2591-8-4-23-b25],[@i2164-2591-8-4-23-b84]

Three studies used an occluder and followed the same procedure. That is, to produce a BRAO the ball was pressed onto an artery emerging from the optic disc.[@i2164-2591-8-4-23-b24],[@i2164-2591-8-4-23-b26],[@i2164-2591-8-4-23-b27]

In one study, including two cats, the probe was used to perform heat coagulation.[@i2164-2591-8-4-23-b24] The success of occlusion was evaluated by inspecting the occluded vessel by direct ophthalmoscopy.

### Embolization {#s3b7}

Studies that applied embolization-based methods were carried out by injecting various substances in either the carotid artery[@i2164-2591-8-4-23-b22],[@i2164-2591-8-4-23-b23],[@i2164-2591-8-4-23-b85] or the maxillary artery.[@i2164-2591-8-4-23-b19][@i2164-2591-8-4-23-b20]--[@i2164-2591-8-4-23-b21]

In three related studies, BRAO was produced in 6 of 27, 12 of 26, and 8 of 33 cases by injecting platelet aggregates, fibrin clots, or leucocyte aggregates, respectively.[@i2164-2591-8-4-23-b19][@i2164-2591-8-4-23-b20]--[@i2164-2591-8-4-23-b21] These experiments also produced microinfarctions and hemorrhages.

Ciulla et al.[@i2164-2591-8-4-23-b22] used human atherosclerotic material, the injection of which produced BRAO in five rabbits and CRAO in four rabbits out of a total 12 animals.

In one study, the injection of air produced BRAO in all animals if they were kept hypotensive.[@i2164-2591-8-4-23-b23] However, the occlusions lasted less than 10 minutes.

Long-acting corticosteroids were injected in one study.[@i2164-2591-8-4-23-b85] Combined with epinephrine, this consistently produced RAO and choriocapillaris occlusion.

### Endovascular Technique {#s3b8}

Three studies using endovascular techniques were identified. All three studies were conducted by Morén et al.[@i2164-2591-8-4-23-b86],[@i2164-2591-8-4-23-b87],[@i2164-2591-8-4-23-b88] and used pigs as experimental animals. The arteries were catheterized using a transfemoral, endovascular approach.

In one study, transient and permanent vascular occlusions were performed using an angioplasty balloon catheter in the ophthalmic artery or a liquid embolic agent that was administered via an injection-catheter.[@i2164-2591-8-4-23-b86] The liquid embolic agent could produce occlusion of either the ophthalmic artery or the main ciliary artery from which the retinal arteries branches. Occlusion of the main ciliary artery produced complete ischemia, in contrast to the ophthalmic artery, which only produced incomplete ischemia.

In the other two studies, vascular occlusion was produced by using coils in the ophthalmic artery.[@i2164-2591-8-4-23-b87],[@i2164-2591-8-4-23-b88]

Evaluation of Successful Occlusion {#s3c}
----------------------------------

In total, 41 of 88 included studies validated their occlusion by the use of fundus examination, while 29 studies used ERG as a measure of the function of the retina. Thirty-three studies used angiography (either fluorescein angiography or indocyanine green angiography), and 33 studies used histopathology to evaluate differences in the architecture of the retina. Twelve studies did not use any of these methods.[@i2164-2591-8-4-23-b16],[@i2164-2591-8-4-23-b17],[@i2164-2591-8-4-23-b27],[@i2164-2591-8-4-23-b29],[@i2164-2591-8-4-23-b44][@i2164-2591-8-4-23-b45]--[@i2164-2591-8-4-23-b46],[@i2164-2591-8-4-23-b61],[@i2164-2591-8-4-23-b63][@i2164-2591-8-4-23-b64]--[@i2164-2591-8-4-23-b65] A few studies used other methods to validate or evaluate the occlusion, such as visual-evoked potential or observing whitening of the iris and the loss of the red reflex. Optical coherence tomography was not performed in any of the studies.

Duration of the Occlusion {#s3d}
-------------------------

When using a setup with ligation, clamp, or increased IOP, the duration of the occlusion was controllable. The applied durations are listed in [Table 3](#i2164-2591-8-4-23-t03){ref-type="table"}. Typically, the occlusion lasted 30 to 90 minutes followed by a varied period of reperfusion.

###### 

Duration of Occlusions and Reperfusion for Studies Using Ligation, Clamping, or High IOP

  Ligation                        Clamp                                                                                              
  ------------------------------- -------------------- -------------------------- ---------------------------------- --------------- --------------------------
  NA                              None                 [@i2164-2591-8-4-23-b79]   15--20, 45, 90 min, 2.25, 4.5 hr   Few hr--3 min   [@i2164-2591-8-4-23-b18]
  30, 60, 120 min, 4, 24 hr       None                 [@i2164-2591-8-4-23-b80]   15--280 min                        Up to 22 wk     [@i2164-2591-8-4-23-b55]
  30 min                          180 min              [@i2164-2591-8-4-23-b83]   NA                                 NA              [@i2164-2591-8-4-23-b60]
  30--90 min                      30 min--24 hr        [@i2164-2591-8-4-23-b82]   At least 116 min                   NA              [@i2164-2591-8-4-23-b58]
  90 min                          4 or 24 hr           [@i2164-2591-8-4-23-b76]   At least 97 min                    Mean 64.5 mo    [@i2164-2591-8-4-23-b59]
  30 min                          180 min              [@i2164-2591-8-4-23-b66]   97--300 min                        NA              [@i2164-2591-8-4-23-b54]
  30 min                          120 min              [@i2164-2591-8-4-23-b67]   97--240 min                        2--16 wk        [@i2164-2591-8-4-23-b05]
  60 min                          Up to 3 d            [@i2164-2591-8-4-23-b72]   3 hr                               6h              [@i2164-2591-8-4-23-b81]
  30 min                          NA                   [@i2164-2591-8-4-23-b68]   97--240 min                        112 ± 111 d     [@i2164-2591-8-4-23-b82]
  30 min                          NA                   [@i2164-2591-8-4-23-b69]                                                      
  1, 5, 10, 20, 30, 60, 120 min   NA                   [@i2164-2591-8-4-23-b81]                                                      
  90 min                          1, 3, 5 min, 24 hr   [@i2164-2591-8-4-23-b77]                                                      
  30 min                          240 min              [@i2164-2591-8-4-23-b70]                                                      
  30 min                          240 min              [@i2164-2591-8-4-23-b71]                                                      
  60 min                          6, 24, 72 hr         [@i2164-2591-8-4-23-b64]                                                      
  60 min                          7 d                  [@i2164-2591-8-4-23-b73]                                                      
  NA                              NA                   [@i2164-2591-8-4-23-b38]                                                      
  90 min                          120 min              [@i2164-2591-8-4-23-b61]                                                      
  NA                              NA                   [@i2164-2591-8-4-23-b65]                                                      
  60 min                          5 d                  [@i2164-2591-8-4-23-b74]                                                      
  90 min                          24 hr                [@i2164-2591-8-4-23-b78]                                                      
  30 or 90 min                    3 or 12 hr           [@i2164-2591-8-4-23-b62]                                                      
  60 min                          10 d                 [@i2164-2591-8-4-23-b75]                                                      
  30 min                          14 d                 [@i2164-2591-8-4-23-b63]                                                      

###### 

Extended

  High IOP                                    
  ---------------- -------------------------- --------------------------
  180 or 240 min   2, 4, or 6 wk               [@i2164-2591-8-4-23-b43]
  45 min           3--48 hr                    [@i2164-2591-8-4-23-b88]
  Up to 60 min     7 d                         [@i2164-2591-8-4-23-b87]
  45 min           7 d                         [@i2164-2591-8-4-23-b63]
  45 m             6 hr--7 d                   [@i2164-2591-8-4-23-b29]
  5 or 10 min      24 hr                       [@i2164-2591-8-4-23-b85]
  50 min           0, 60 min, 6 or 24 hr       [@i2164-2591-8-4-23-b44]
  60 min           1, 3, 5, 7, 14 d            [@i2164-2591-8-4-23-b61]
  90 min           1 d                         [@i2164-2591-8-4-23-b62]
  60 min           NA                          [@i2164-2591-8-4-23-b45]
  60 min           0, 60 min, 6, 24 hr, 7 d    [@i2164-2591-8-4-23-b84]

Endovascular approach was permanent, except when using balloon catheter, in which case the artery was occluded for 1 hour.[@i2164-2591-8-4-23-b86]

When inducing an occlusion by laser, the duration of the occlusion has a methodologic limit as spontaneous reperfusion occurs at a point, either due to recanalization or development of collateral circulation. Ten of 23 studies using laser reported the duration of the occlusions (see [Table 4](#i2164-2591-8-4-23-t05){ref-type="table"}). Large differences existed between studies with the duration varying from 3 hours to 2 weeks before reperfusion. In many cases, there were no data on the exact time of reperfusion, but intervals, minimums, or maximums were given for the duration of the occlusion. One study induced reperfusion by infusion of recombinant tissue plasminogen activator.[@i2164-2591-8-4-23-b10]

###### 

Reported Duration of Artery Occlusion Induced by Laser Before Spontaneous Reperfusion^a^

  Species               Method                                                          Site of Occlusion                                     Reported Duration of Artery Occlusion   Reference
  --------------------- --------------------------------------------------------------- ----------------------------------------------------- --------------------------------------- --------------------------
  Rodents               Light + rose bengal                                             BRAO                                                  \>60 min                                [@i2164-2591-8-4-23-b08]
  Rodents               Laser + rose bengal                                             CRAO                                                  ∼6 hr                                   [@i2164-2591-8-4-23-b31]
  Rodents               Laser + rose bengal                                             CRAO                                                  3hr to \>24 hr                          [@i2164-2591-8-4-23-b30]
  Rabbits               Laser + rose bengal                                             RAO (all arteries)                                    8 hr--1 d                               [@i2164-2591-8-4-23-b37]
  Rodents               Laser + rose bengal                                             CRAO                                                  At least 24--48 hr                      [@i2164-2591-8-4-23-b32]
  Rabbits               Light + rose bengal                                             BRAO (and CRVO)                                       \<3 d                                   [@i2164-2591-8-4-23-b07]
  Rodents               White light + rose bengal                                       BRAO                                                  Up to 3 d                               [@i2164-2591-8-4-23-b09]
  Rabbits               Laser + phthalocyanine                                          Vein and artery branch + choroidal vessels            2--4 d                                  [@i2164-2591-8-4-23-b11]
  Rabbits               Laser + chloro-aluminum sulfonated phthalocyanine               Medullary ray (artery, vein, and choroidal vessels)   72 hr --1 wk                            [@i2164-2591-8-4-23-b28]
  Rabbits and rodents   Laser targeted delivery + encapsulated photosensitizing agent   BRAO                                                  At least 2 wk                           [@i2164-2591-8-4-23-b12]

For studies reporting information on the duration only.

Studies using an occluder or probe maintained the occlusion for periods ranging from 10 minutes to 4 hours.[@i2164-2591-8-4-23-b24][@i2164-2591-8-4-23-b25][@i2164-2591-8-4-23-b26]--[@i2164-2591-8-4-23-b27]

Constriction caused by endothelin-1 infusion was in one study reported to last for approximately 5 minutes after which the effect declines,[@i2164-2591-8-4-23-b16] other studies found it to last for at least 50 minutes.[@i2164-2591-8-4-23-b39],[@i2164-2591-8-4-23-b40] Injection in the subconjunctival space caused constriction for 30 minutes.[@i2164-2591-8-4-23-b41]

One study using embolization by injecting leukocyte aggregates and subsequently exposing the animals to hypoxia reported the occlusions to last up to 8 days.[@i2164-2591-8-4-23-b20] Studies using other agents reported occlusions lasting up to 166 seconds or 20 minutes.[@i2164-2591-8-4-23-b19],[@i2164-2591-8-4-23-b23]

Discussion {#s4}
==========

Experimental animal models offer a unique opportunity to investigate different aspects of RAO. However, caution is needed when findings are extrapolated to the disease in humans. In order to increase the usefulness and applicability of RAO experiments, it is of utmost importance to imitate the human disease as closely as possible. Ideally, the anatomy of the animal should resemble that of the human eye, the intervention should mimic the occlusion of the retinal artery meaning the occlusion of the retinal artery only, and avoid damage on other tissues or structures.

Imitating the disease requires thorough knowledge on the natural history of RAO. In this aspect, the duration and extent of the occlusion is of interest. In a fluorescein angiography study in which patients were seen 4.4 days in average after the onset of symptoms, only one in 62 patients with CRAO showed complete absence of dye in the retinal arteries.[@i2164-2591-8-4-23-b98] However, the arteriovenous transit time was found to be prolonged in most cases. Hence, while there seems to be consensus that in the clinical setting some residual circulation remains, the mechanism is still debated. It has been suggested to be due to an incomplete obstruction by the embolus in the vessel.[@i2164-2591-8-4-23-b30],[@i2164-2591-8-4-23-b99],[@i2164-2591-8-4-23-b100] A study by Hayreh and Jonas[@i2164-2591-8-4-23-b54] on clamping of the CRA in monkeys reported of fluorescein angiographies similar to that in humans showing residual circulation after CRAO. It was argued that it was due to anastomoses with the CRA distal to the occlusion allowing filling, that being cilioretinal capillary anastomoses and pial and intraneural anastomoses.[@i2164-2591-8-4-23-b54] This mechanism is only possible if the site of occlusion is proximal to the site of these anastomoses (i.e., the dural sheath). Experimental methods using increased IOP, ligation of multiple vessels, and vasoconstriction causes complete obstruction of the vessel(s) leaving no residual circulation, in contrast to the clinical picture in man.

Due to time delay, the clinical findings at the very onset of the occlusion is largely unknown. Although it is uncertain when it begins, reperfusion ultimately occurs in the majority of clinical cases. Hence, one study found reperfusion to appear in all cases of RAO, although in only 16 of the 29 patients with visible emboli perfusion recovered within the first month.[@i2164-2591-8-4-23-b97] A study on CRAO found only 15% of eyes to have transient CRAO (lasting several minutes to many hours), while 71% had permanent CRAO, and 14% had CRAO with cilioretinal artery sparing.[@i2164-2591-8-4-23-b101] In the vast majority of the experimental studies, the occlusion lasted only minutes to hours followed by either spontaneous or induced/intended reperfusion. Only the endovascular method produced permanent occlusion. Therefore, it could be argued there are dissimilarities between the majority of the experimental setups and the longer lasting CRAO in humans.

It has previously been argued in a study using laser-induced thrombus that animal models that depend on well-controlled reperfusion may produce pathogenic information that is less relevant to the clinical situation.[@i2164-2591-8-4-23-b30] It is argued that there is improved clinical relevance in a CRAO model with an intraluminal thrombus that can resolve naturally and spontaneously and with long-term ischemia. On the other hand, such a setup is less standardized and reproducible.

Reperfusion following ischemia is thought to cause damage to the tissue.[@i2164-2591-8-4-23-b06] If reperfusion takes place after irreversible damage on the retina has already happened due to the ischemia, it may be less relevant to allow reperfusion to happen in an experimental model. This is especially true for studies investigating biochemical responses with the objective to search for potential mechanism of treatment.

A disadvantage of several of the models is that they affect vessels other than the retinal artery. Endothelin-1 causes constriction of all retinal vessels, including veins. One study investigated the choroidal blood flow following the administration of endothelin-1 in rabbits.[@i2164-2591-8-4-23-b40] They found the choroidal blood flow to increase, maybe due to regulatory mechanisms. As for the method of increased IOP, even a moderate increase in IOP causes a reduction in blood flow in the choroid.[@i2164-2591-8-4-23-b40],[@i2164-2591-8-4-23-b102],[@i2164-2591-8-4-23-b103] In the majority of studies using ligature, the ciliary arteries were ligated as well. Injection of material to cause embolization was done in either the carotid or maxillary artery, which may very well have caused ischemia in tissues other than the retina. When using an occluder or probe only the inner retina is made ischemic. The same applies for clamp in monkeys, laser, and, to some extent, endovascular approach.

Some methods could produce features unrelated to RAO, too. Elevation of IOP may result in both vascular occlusion--induced ischemia and mechanical injury to the retina. Öz et al.[@i2164-2591-8-4-23-b47] reported that their model of increased IOP, "...has no similarity or analogy to isolated vascular occlusion such as clinical central retinal artery occlusion or ophthalmic artery occlusion." Ligation often included ligation of the optic nerve. This induces mechanical and ischemic damage to the optic nerve and may also induce occlusion of the ciliary arteries resulting in choroidal ischemia. This may confound the cell degeneration attributed to ischemic damage from occlusion of the CRA. Furthermore, ligation and clamping are invasive, requiring dissection of the orbit area. Using laser may cause damage due to the use of photosensitizer and/or the laser itself.[@i2164-2591-8-4-23-b06] Furthermore, it seems unavoidable to damage the optic nerve and possibly the central retinal vein if CRAO is produced by applying laser to the optic nerve.

Of all species used in these studies, the anatomy of the nonhuman primates resembles that of the human eye most closely, followed by that of pigs. On the contrary, the rabbit appears to be a poor choice in experimental models of human retinal artery occlusions.[@i2164-2591-8-4-23-b96],[@i2164-2591-8-4-23-b38] Besides from the anatomy and the resemblance with human eyes, other factors are to be considered in regard to the different species. The size of the animal and the eye is of importance. Smaller animals may be easier to handle and require smaller housing facilities. On the other hand, larger animals with eyes with the size of human eyes, such as the pig, are an advantage or necessity in surgical methods, such as endovascular approach or ligation of only the CRA. Other factors include availability of the species and economy.

If other researchers are to replicate previous animal studies and benefit from their experience, the method should be reproduceable. Especially the embolization method causes varied results and only some of the experiments resulted in BRAO. In addition, there is limited experience with some methods as they were only reported in few studies (studies on occluder/probe, endovascular technique, embolization).

To ensure critical evaluation and transparency, studies should validate their method, ideally by fundus examination, angiography, and ERG. These results should then be reported. Multiple of the included studies did not use any of these common methods, and many of those that did, did not document their findings. This makes it difficult to compare studies as the evaluation of successful occlusion is so diverse.

Conclusion and Recommendations for Future Research {#s5}
==================================================

Although a broad range of approaches can be used to model RAO in animals, future research on RAO should use a suitable animal model, which is anatomically and physiologically similar to humans. Therefore, monkeys followed by pigs are to be preferred and conversely, the rabbit appears to be a poor choice. In addition, an animal model of RAO must have an occlusion pattern that resembles occlusive mechanisms in the human eye. A number of animal models of RAO induce general ocular ischemia resembling ocular ischemic syndrome. Models that induce global ocular ischemia may not be well suited for studying RAO. We recommend methods that result in RAO without damages to adjacent ocular structures. Also, the duration and extent of the ischemic period should mimic that in RAO in humans. Although none of the described methods meet all of the criteria of a perfect model some methods seem to be superior compared with others. Though it is invasive, ligation or clamp may be a suitable model in larger animals as there is a potential to isolate and occlude the retinal artery only. Laser-induced occlusion is another suitable approach being noninvasive and involving the retinal artery only. However, our review demonstrates that reperfusion of the occlusion is likely to occur. IOP, vasoconstriction, and embolization may be less suitable models as the resulting ischemia is not specific or stable enough. Regardless of the model, documentation and validation by fundus photography and angiography are indispensable for a successful study.

As no existing model is ideal, the methods may supplement each other and model various specific aspects of the disease, and thereby each contribute to the understanding of the disease. Hence, a surgical or laser-induced occlusion allows the basic reaction of the tissue to the occlusion to be studied, although the formation of a thrombosis or embolus in humans may not be mimicked completely. However, future studies are needed to develop a model with an actual thromboembolism useful in the development of treatments targeting the thrombus or emboli itself, such as thrombolytics and surgical removal of the embolus.

Supplementary Material
======================

###### 

Click here for additional data file.
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